About Us

Mission

Removing the barriers to CKD testing by creating accessible and affordable lab- equivalent technologies.

Vision

Affordable and accessible diagnostics for everyone, including nurses, patients, and loved ones.

Assure CKD’s History

Founding Story

AssureCKD is built on over a decade of innovation, collaboration, and a shared vision to transform how chronic kidney disease (CKD) is detected and managed.

Our journey began in 2013, when Dr. Claudio Rigatto and Dr. Francis Lin first joined forces to explore the potential of microfluidic technology for point-of-care diagnostics. With the support of a major national grant in 2014, their work facilitated years of groundbreaking research, personnel training, joint publications, and patent development, laying the scientific foundation for what would eventually become MATLOC.

Even during the global disruption of COVID-19, development of the technology continued through a combination of public and private support. By 2024, the technology had evolved into a fully integrated lab-on-chip platform and was licensed to AssureCKD to take it forward into clinical and commercial reality.

Today, AssureCKD is a team of nine and growing. We’re advancing the MATLOC system through FDA and Health Canada regulatory pathways to bring lab-equivalent CKD screening and diagnostic testing directly to the point-of-care. By improving access to early detection, we aim to help slow or even prevent

progression to end-stage kidney failure, improving lives while reducing the burden on healthcare systems.

Our network includes partnerships with exceptional companies across various industries.

Partnerships

Meet the team behind the mission

  • Harrison Ross

    CFA CEO

    Principal at Rydra Capital Corp.

    Director at Duncan Ross Associates.

  • Claudio Rigatto

    MD, FRCPC CMO

    Professor, University of Manitoba.

    Past President, Canadian Society of Nephrology.

  • Jared Schacter

    COO, Fractional

    Previously with McKinsey and Uber.

    Has helped companies through 6+ exits.

  • George Kovalyov

    CPA (Director)

    Officer and Director of (NASDAQ/OTC/TSXV) corporate entities.

    Expert financial controller.

  • Navdeep Tangri

    MD, PhD, FRCPC (Director)

    Founder of the Kidney Failure Risk Equation (KFRE).

    Founder of Klinrisk.

  • Paul Komenda

    MD, MHA, FRCPC, FASN (Director)

    Chief Medical Officer at Quanta Dialysis.

    Fellow of the American Society of Nephrology.

  • Francis Lin

    PHD Technology
    Founder

    Department of Immunology Physics and Astronomy University of Manitoba.